Also, the FDA appointed 4 men to senior leadership roles, including the newly created position of deputy commissioner for technology and AI.
Symptoms that persist for three months or more are also common after other respiratory viral infections like the flu and RSV.
Things no longer reliably provided by the CDC: What vaccines are recommended, whether you can walk in and get one, and what's happening with disease in the US.
The vaccine was an estimated 73% effective at preventing hospitalizations and 56% effective in protecting against death.
The groups, along with other leading US medical organizations, offer vaccine recommendations for the upcoming respiratory illness season.
Our researchers systematically reviewed the newest scientific evidence on flu, COVID-19, and RSV immunizations, examining effectiveness and safety.
A new study finds that the vaccine was 78% effective for any RSV-associated lower respiratory tract disease through age 6 months.
Respiratory syncytial viruses are linked to nasal colonization with Streptococcus pneumonia, but their specific role is still unclear.
A vaccine given to pregnant women and an antibody therapy given to newborns both protect babies during their first respiratory virus season.
Researchers say the results suggest the monoclonal antibody could be a tool for antibiotic stewardship.
